We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
1126
Ocular Therapeutix
OCUL
$1.89B
$2K ﹤0.01%
134
OMER icon
1127
Omeros
OMER
$816M
$2K ﹤0.01%
116
PCVX icon
1128
Vaxcyte
PCVX
$8.03B
$2K ﹤0.01%
96
PLRX icon
1129
Pliant Therapeutics
PLRX
$67.5M
$2K ﹤0.01%
67
PSNL icon
1130
Personalis
PSNL
$1.28B
$2K ﹤0.01%
73
RIGL icon
1131
Rigel Pharmaceuticals
RIGL
$693M
$2K ﹤0.01%
37
RNAM
1132
DELISTED
Avidity Biosciences
RNAM
$2K ﹤0.01%
71
RPTX
1133
DELISTED
Repare Therapeutics
RPTX
$2K ﹤0.01%
69
RYTM icon
1134
Rhythm Pharmaceuticals
RYTM
$7.3B
$2K ﹤0.01%
98
SNDX icon
1135
Syndax Pharmaceuticals
SNDX
$1.82B
$2K ﹤0.01%
93
SRRK icon
1136
Scholar Rock
SRRK
$5.87B
$2K ﹤0.01%
63
STOK icon
1137
Stoke Therapeutics
STOK
$1.83B
$2K ﹤0.01%
68
STRO icon
1138
Sutro Biopharma
STRO
$398M
$2K ﹤0.01%
9
TBPH icon
1139
Theravance Biopharma
TBPH
$874M
$2K ﹤0.01%
120
TVTX icon
1140
Travere Therapeutics
TVTX
$5.28B
$2K ﹤0.01%
114
KLRS
1141
Kalaris Therapeutics
KLRS
$85.2M
$2K ﹤0.01%
5
PETQ
1142
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
55
GTHX
1143
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
72
AERI
1144
DELISTED
Aerie Pharmaceuticals
AERI
$2K ﹤0.01%
102
CCXI
1145
DELISTED
ChemoCentryx, Inc.
CCXI
$2K ﹤0.01%
137
FMTX
1146
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2K ﹤0.01%
89
ENDP
1147
DELISTED
Endo International plc
ENDP
$2K ﹤0.01%
433
RDUS
1148
DELISTED
Radius Health, Inc.
RDUS
$2K ﹤0.01%
88
EPZM
1149
DELISTED
Epizyme, Inc
EPZM
$2K ﹤0.01%
191
ZGNX
1150
DELISTED
Zogenix, Inc.
ZGNX
$2K ﹤0.01%
105

Similar funds

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.